View Featured Offers >>
12856
PathScan® Stress and Apoptosis Signaling Antibody Array Kit (Chemiluminescent Readout)
Antibody Array Kit

PathScan® Stress and Apoptosis Signaling Antibody Array Kit (Chemiluminescent Readout) #12856

Citations (1)
Figure 1. Target map of the PathScan® Stress and Apoptosis Signaling Antibody Array Kit (Chemiluminescent Readout) #12856.
Figure 2. HT-29 cells were grown to 80% confluency and then either untreated (left panel) or UV-irradiated and allowed to recover for 60 minutes (right panel). Cell extracts were prepared and analyzed using the PathScan® Stress and Apoptosis Signaling Antibody Array Kit (Chemiluminescent Readout) #12856. Images were acquired by briefly exposing the slide to standard chemiluminescent film.
Figure 3. HeLa cells were grown to 90% confluency and then either untreated (left panel) or treated with Human Tumor Necrosis Factor-α (hTNF-α) #8902 (100 ng/ml, 20 min; right panel). Cell extracts were prepared and analyzed using the PathScan® Stress and Apoptosis Signaling Antibody Array Kit (Chemiluminescent Readout) #12856. Images were acquired by briefly exposing the slide to standard chemiluminescent film.
Figure 4. HeLa cells were grown to 90% confluency and then serum starved overnight. Cells were either untreated (left panel) or treated with Human Transforming Growth Factor β3 (hTGF-β3) #8425 (100 ng/ml, 20 min; right panel). Cell extracts were prepared and analyzed using the PathScan® Stress and Apoptosis Signaling Antibody Array Kit (Chemiluminescent Readout) #12856. Images were acquired by briefly exposing the slide to standard chemiluminescent film.
Figure 5. HeLa cells were grown to 90% confluency and then either untreated (left panel) or treated with Staurosporine #9953 (1 μM, 3.5 hr; right panel). Cell extracts were prepared and analyzed using the PathScan® Stress and Apoptosis Signaling Antibody Array Kit (Chemiluminescent Readout) #12856. Images were acquired by briefly exposing the slide to standard chemiluminescent film.
Inquiry Info.# 12856

Product Description

The PathScan® Stress and Apoptosis Signaling Antibody Array Kit (Chemiluminescent Readout) uses glass slides as the planar surface and is based upon the sandwich immunoassay principle. The array kit allows for the simultaneous detection of 19 signaling molecules that are involved in the regulation of the stress response and apoptosis. Target-specific capture antibodies have been spotted in duplicate onto nitrocellulose-coated glass slides. Each kit contains two slides allowing for the interrogation of 32 different samples and the generation of 608 data points in a single experiment. Cell lysates are incubated on the slide followed by a biotinylated detection antibody cocktail. Streptavidin-conjugated HRP and LumiGLO® Reagent are then used to visualize the bound detection antibody by chemiluminescence. An image of the slide can be captured with either a digital imaging system or standard chemiluminescent film. The image can be analyzed visually or the spot intensities quantified using array analysis software.

Storage

Kit should be stored at 4°C with the exception of Lysis Buffer, which is stored at –20°C (packaged separately).

Specificity / Sensitivity

PathScan® Stress and Apoptosis Signaling Antibody Array Kit (Chemiluminescent Readout) detects the target proteins as specified on the Array Target Map. No substantial cross-reactivity has been observed between targets. This kit is optimized for cell lysates diluted to a total protein concentration between 0.2 and 1 mg/ml (see kit protocol).

Species Reactivity:

Human

Background

Cell death can occur due to a variety of circumstances including nutrient deprivation, inability to generate or store the energy required for metabolic functions, or deleterious environment that causes irreparable damage. Cells integrate multiple signals from a variety of sources before following either pro- or anti-apoptotic pathways. These signals can often carry conflicting information. Assessing the net effect of these processes in cell populations can be achieved by monitoring changes in a number of key signaling components. The caspase-3 and caspase-7 proteases exert a pro-apoptotic function through cleavage of multiple cellular targets. Caspase-3 and caspase-7 are activated by cleavage at Asp175 and Asp198, respectively. PARP is a DNA repair and apoptosis enzyme that is inactivated by cleavage at Asp214 by caspase-3 or caspase-7. HSP27 is a mediator of cell stress that confers resistance to adverse environmental conditions. HSP27 is activated by phosphorylation at Ser82. Chk1 and Chk2 kinases act downstream of ATM/ATR and play an important role in DNA damage checkpoint control. Activation of Chk1 and Chk2 involve phosphorylation at Ser345 and Thr68, respectively. Tumor suppressor p53 plays an important role in cellular response to DNA damage. p53 is phosphorylated at Ser15 by ATM/ATR or DNA-PK leading to its accumulation. Smad2 is a key mediator of TGF-β signaling. Stimulation by TGF-β leads to Smad2 phosphorylation at Ser465/467 and translocation of Smad2 into the nucleus. The outcome of TGF-β signaling is context dependent and can either induce apoptosis or contribute to tumor cell metastasis. Activation of NF-κB/Rel occurs through a proteasome-mediated degradation of IκBα. The inhibitor IκBα is targeted to the proteasome via phosphorylation of IκBα at Ser32 and Ser36. NF-κB activation is triggered by a diverse group of extracellular signals promoted by inflammatory cytokines, growth factors, and chemokines. TAK1 is a kinase that can be activated by TGF-β, bone morphogenetic proteins and other cytokines. Activated TAK1 phosphorylates MKK4, MKK3/6, and NIK. Phosphorylation of TAK1 at Ser412 is one of the mechanisms that regulate the levels of its activation. Cellular stress such as viral infection, endoplasmic reticulum stress, and amino acid deprivation leads to phosphorylation of eIF2α. Phosphorylation of eIF2α at Ser51 in response to cellular stress leads to a reduction of protein synthesis. The ERK1 and ERK2 MAP kinases are major signaling nodes that have many substrates and primarily transmit growth and proliferation signals. The ERK MAP kinase is activated by a dual phosphorylation of Thr202 and Tyr204. p38 MAPK and SAPK/JNK MAP kinases are activated through a similar dual phosphorylation mechanism in response to pro-inflammatory cytokines and genotoxic stress. Akt is activated by stimulation of growth-factor receptors and primarily promotes anabolic growth and survival signals via targeting its broad array of substrates. Akt phosphorylates Bad at Ser136 and inhibits its ability to induce apoptosis. Survivin is an anti-apoptotic protein that is highly expressed during fetal development and cancer cell malignancy. Survivin binds and inhibits caspase-3, controlling the cell cycle by inhibiting apoptosis and promoting cell division. α-tubulin is a building block of microtubules that are present in all eukaryotic cells. The levels of the globular α-tubulin are considered to remain relatively constant. Therefore, assessing the relative levels of α-tubulin may assist with signal normalization between the various samples.

  1. Boatright, K.M. and Salvesen, G.S. (2003) Curr Opin Cell Biol 15, 725-31.
  2. Cohen, G.M. (1997) Biochem J 326 ( Pt 1), 1-16.
  3. Bratton, S.B. and Cohen, G.M. (2001) Trends Pharmacol Sci 22, 306-15.
  4. Green, D.R. and Reed, J.C. (1998) Science 281, 1309-12.
  5. Basu, S. and Kolesnick, R. (1998) Oncogene 17, 3277-85.
  6. Jeremias, I. and Debatin, K.M. (1998) Eur Cytokine Netw 9, 687-8.
  7. Aravind, L. et al. (1999) Trends Biochem Sci 24, 47-53.
  8. Bates, S. and Vousden, K.H. (1999) Cell Mol Life Sci 55, 28-37.
  9. Heyninck, K. and Beyaert, R. (2001) Mol Cell Biol Res Commun 4, 259-65.
  10. Abe, K. et al. (2000) Ann N Y Acad Sci 926, 52-63.
  11. Rath, P.C. and Aggarwal, B.B. (1999) J Clin Immunol 19, 350-64.
  12. Holoch, P.A. and Griffith, T.S. (2009) Eur J Pharmacol 625, 63-72.
  13. Gjertsen, B.T. and Døskeland, S.O. (1995) Biochim Biophys Acta 1269, 187-99.
  14. Clemens, M.J. (2001) Prog Mol Subcell Biol 27, 57-89.
  15. Janes, K.A. et al. (2005) Science 310, 1646-53.
  16. Janes, K.A. et al. (2008) Cell 135, 343-54.

Limited Uses

Except as otherwise expressly agreed in a writing signed by a legally authorized representative of CST, the following terms apply to Products provided by CST, its affiliates or its distributors. Any Customer's terms and conditions that are in addition to, or different from, those contained herein, unless separately accepted in writing by a legally authorized representative of CST, are rejected and are of no force or effect.

Products are labeled with For Research Use Only or a similar labeling statement and have not been approved, cleared, or licensed by the FDA or other regulatory foreign or domestic entity, for any purpose. Customer shall not use any Product for any diagnostic or therapeutic purpose, or otherwise in any manner that conflicts with its labeling statement. Products sold or licensed by CST are provided for Customer as the end-user and solely for research and development uses. Any use of Product for diagnostic, prophylactic or therapeutic purposes, or any purchase of Product for resale (alone or as a component) or other commercial purpose, requires a separate license from CST. Customer shall (a) not sell, license, loan, donate or otherwise transfer or make available any Product to any third party, whether alone or in combination with other materials, or use the Products to manufacture any commercial products, (b) not copy, modify, reverse engineer, decompile, disassemble or otherwise attempt to discover the underlying structure or technology of the Products, or use the Products for the purpose of developing any products or services that would compete with CST products or services, (c) not alter or remove from the Products any trademarks, trade names, logos, patent or copyright notices or markings, (d) use the Products solely in accordance with CST Product Terms of Sale and any applicable documentation, and (e) comply with any license, terms of service or similar agreement with respect to any third party products or services used by Customer in connection with the Products.

For Research Use Only. Not for Use in Diagnostic Procedures.
Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
PathScan is a registered trademark of Cell Signaling Technology, Inc.
All other trademarks are the property of their respective owners. Visit our Trademark Information page.